论文部分内容阅读
治疗反应的可靠性是勃起功能障碍(ED)治疗的一项重要组成部分。本研究对他达拉非每日给药一次治疗方案在首次性交成功后的可靠性(即性交尝试成功次数/总性交尝试次数)进行了研究。研究者对两项随机化、双盲、安慰剂对照临床试验的数据进行了汇总,以确定在该两项研究中每日一次服用2.5 mg他达拉非(n=96例)或5 mg他达拉非(n=206例)及安慰剂(n=148)的ED患者的首次性交尝试成功率以及随后
The reliability of the treatment response is an important part of the treatment of erectile dysfunction (ED). In this study, we examined the reliability of tadalafil once daily dosing regimen after successful first sexual intercourse (ie, the number of successful sexual intercourse trials / total intercourse attempts). The researchers summarized data from two randomized, double-blind, placebo-controlled clinical trials to determine if 2.5 mg of tadalafil (n = 96) or 5 mg was taken daily in both studies The success rate of first sexual intercourse trial for ED patients with dalafel (n = 206) and placebo (n = 148) and subsequent